Europe Functional Genomics Market

2.1 Functional Genomics Workflow Analysis
2.2 Future Potential
2.3 Impact of Functional Genomics
      2.3.1 Gene Therapy
      2.3.2 Drug Discovery and Development
      2.3.3 Gene Expression
      2.3.4 Single-Cell Analysis

3.1 Overview
3.2 Europe
      3.2.1 Germany
      3.2.2 France
      3.2.3 U.K.
      3.2.4 Italy
      3.2.5 Spain
      3.2.6 Rest-of-Europe

4.1 Overview
4.2 F. Hoffmann-La Roche Ltd
          4.2.1 Company Overview
          4.2.2 Role of F. Hoffmann-La Roche Ltd in the  Functional Genomics Market
          4.2.3 Financials
          4.2.4 Key Insights about the Financial Health of the Company
          4.2.5 Recent Developments
          4.2.6 Analyst Perspective
4.3 Merck KGaA
          4.3.1 Company Overview
          4.3.2 Role of Merck KGaA in the  Functional Genomics Market
          4.3.3 Financials
          4.3.4 Key Insights about the Financial Health of the Company
          4.3.5 Analyst Perspective
4.4 QIAGEN
          4.4.1 Company Overview
          4.4.2 Role of QIAGEN in the  Functional Genomics Market
          4.4.3 Financials
          4.4.4 Key Insights about the Financial Health of the Company
          4.4.5 Recent Developments
          4.4.6 Analyst Perspective

Table 1: Europe Functional Genomics Market: Impact Analysis
Table 2: Technological Trends in  Functional Genomics Market
Table 3: Europe: Market Dynamics

Figure 1: Europe Functional Genomics Market, $Billion, 2023 and 2033
Figure 2: Biological Features of Functional Genomics Approaches
Figure 3: Share of  Functional Genomics Market (by Region), 2022
Figure 4: Functional Genomics Market: Research Methodology
Figure 5: Primary Research Methodology
Figure 6: Bottom-Up Approach (Segment-Wise Analysis)
Figure 7: Top-Down Approach (Segment-Wise Analysis)
Figure 8: Epigenomics Workflow
Figure 9: Transcriptomics Workflow
Figure 10: Proteomics Workflow
Figure 11: Metabolomics Workflow
Figure 12: Functional Genomics Market Snapshot (by Region)
Figure 13: Functional Genomics Market (by Region), $Billion, 2023-2033
Figure 14: Europe Functional Genomics Market, $Billion, 2022-2033
Figure 15: Europe Functional Genomics Market (by Country), $Billion, 2022-2033
Figure 16: Germany Functional Genomics Market, $Billion, 2022-2033
Figure 17: France Functional Genomics Market, $Billion, 2022-2033
Figure 18: U.K. Functional Genomics Market, $Billion, 2022-2033
Figure 19: Italy Functional Genomics Market, $Billion, 2022-2033
Figure 20: Spain Functional Genomics Market, $Billion, 2022-2033
Figure 21: Rest-of-Europe Functional Genomics Market, $Billion, 2022-2033
Figure 22: Functional Genomics Market, Total Number of Key Companies Profiled
Figure 23: F. Hoffmann-La Roche Ltd: Product Portfolio
Figure 24: F. Hoffmann-La Roche Ltd: Overall Financials, 2020-2022
Figure 25: F. Hoffmann-La Roche Ltd: Revenue (by Segment), 2020-2022
Figure 26: F. Hoffmann-La Roche Ltd: R&D Expenditure, 2020-2022
Figure 27: Merck KGaA: Product Portfolio
Figure 28: Merck KGaA: Overall Financials, $Million, 2020-2022
Figure 29: Merck KGaA: Revenue (by Segment), $Million, 2020-2022
Figure 30: Merck KGaA: Revenue (by Region), $Million, 2020-2022
Figure 31: Merck KGaA: R&D Expenditure, $Million, 2020-2022
Figure 32: QIAGEN.: Product Portfolio
Figure 33: QIAGEN: Overall Financials, $Million, 2019-2021
Figure 34: QIAGEN: Revenue (by Segment), $Million, 2019-2021
Figure 35: QIAGEN: Revenue (by Region), $Million, 2019-2021
Figure 36: QIAGEN N.V.: R&D Expenditure, $Million, 2019-2021